Publication | Open Access
Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial
12
Citations
33
References
2022
Year
Metabolic SyndromeDiabetes ManagementDiabetesClinical TrialsPlacebo-controlled TrialPharmacotherapyDiabetes MellitusMedicineHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1